Bd leverages artificial intelligence to transform microbiology urine testing

Franklin lakes, n.j., may 26, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the u.s. launch of a urine culture application for use with the bd kiestra™ lab automation incubation and imaging system that can transform the way microbiology labs approach urine culture analysis.
BDX Ratings Summary
BDX Quant Ranking